An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,003 | 18,220 | 19,985 | 21,351 | 33,504 |
| Marketable Securities | 43,918 | 44,696 | 47,075 | 62,267 | 59,922 |
| TOTAL | $64,016 | $67,524 | $69,559 | $86,262 | $97,689 |
| Non-Current Assets | |||||
| Investments And Advances | 3,219 | 8,301 | 11,480 | 5,021 | 0 |
| Other Non-Current Assets | 0 | 0 | 304 | 804 | 0 |
| TOTAL | $3,219 | $8,301 | $11,784 | $5,825 | $N/A |
| Total Assets | $67,235 | $75,825 | $81,343 | $92,087 | $97,689 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,226 | 2,113 | 3,073 | 3,317 | 1,711 |
| Accrued Expenses | 4,449 | 4,153 | 4,572 | 6,130 | 7,031 |
| Other current liabilities | 183 | 717 | 369 | 791 | 1,275 |
| TOTAL | $6,858 | $6,983 | $8,014 | $10,238 | $10,017 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,858 | $6,983 | $8,014 | $10,238 | $10,017 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,402 | 27,326 | 30,176 | 30,099 | 29,879 |
| Retained earnings | -232,240 | -222,887 | -216,425 | -205,776 | -198,254 |
| Other shareholders' equity | 64 | 25 | 48 | 31 | 112 |
| TOTAL | $60,377 | $68,842 | $73,329 | $81,849 | $87,672 |
| Total Liabilities And Equity | $67,235 | $75,825 | $81,343 | $92,087 | $97,689 |